These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35475172)

  • 41. Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
    Bradshaw CM; Georgieva T; Tankersley TN; Taylor-Doyle T; Johnson L; Uhrlaub JL; Besselsen D; Nikolich JŽ
    J Immunol; 2024 Feb; 212(4):523-528. PubMed ID: 38197714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infiltrating monocytes drive cardiac dysfunction in a cardiomyocyte-restricted mouse model of SARS-CoV-2 infection.
    Dmytrenko O; Das S; Kovacs A; Cicka M; Liu M; Scheaffer SM; Bredemeyer A; Mack M; Diamond MS; Lavine KJ
    J Virol; 2024 Sep; 98(9):e0117924. PubMed ID: 39207134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
    Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
    Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
    Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
    PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection.
    Achom A; Das R; Pakray P
    Comput Biol Med; 2022 Dec; 151(Pt A):106050. PubMed ID: 36334362
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.
    Alvarado DM; Son J; Thackray LB; Diamond MS; Ding S; Ciorba MA;
    bioRxiv; 2021 Aug; ():. PubMed ID: 34373857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection.
    Drelich AK; Rayavara K; Hsu J; Saenkham-Huntsinger P; Judy BM; Tat V; Ksiazek TG; Peng BH; Tseng CK
    PLoS Pathog; 2024 Jun; 20(6):e1011777. PubMed ID: 38913740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Generation of SARS-CoV-2 Mouse Model by Transient Expression of the Human ACE2 Gene Mediated by Intranasal Administration of AAV-hACE2].
    Glazkova DV; Bogoslovskaya EV; Urusov FA; Kartashova NP; Glubokova EA; Gracheva AV; Faizuloev EB; Trunova GV; Khokhlova VA; Bezborodova OA; Pankratov AA; Leneva IA; Shipulin GA
    Mol Biol (Mosk); 2022; 56(5):774-782. PubMed ID: 36165016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
    Jiang RD; Liu MQ; Chen Y; Shan C; Zhou YW; Shen XR; Li Q; Zhang L; Zhu Y; Si HR; Wang Q; Min J; Wang X; Zhang W; Li B; Zhang HJ; Baric RS; Zhou P; Yang XL; Shi ZL
    Cell; 2020 Jul; 182(1):50-58.e8. PubMed ID: 32516571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
    Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia.
    Helal MA; Shouman S; Abdelwaly A; Elmehrath AO; Essawy M; Sayed SM; Saleh AH; El-Badri N
    J Biomol Struct Dyn; 2022 Feb; 40(3):1109-1119. PubMed ID: 32936048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. hACE2 upregulation and participation of macrophages and clear cells in the immune response of epididymis to SARS-CoV-2 in K18-hACE2 mice.
    da Silva AAS; de Oliveira SA; Battistone MA; Hinton BT; Cerri PS; Sasso-Cerri E
    Andrology; 2024 Oct; ():. PubMed ID: 39363435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
    Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
    Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2.
    Miluzio A; Cuomo A; Cordiglieri C; Donnici L; Pesce E; Bombaci M; Conti M; Fasciani A; Terracciano L; Manganaro L; Toccafondi M; Scagliola A; Oliveto S; Ricciardi S; Grifantini R; De Francesco R; Abrignani S; Manfrini N; Biffo S
    EBioMedicine; 2023 Jan; 87():104390. PubMed ID: 36584595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues.
    Qiao J; Li W; Bao J; Peng Q; Wen D; Wang J; Sun B
    Biochem Biophys Res Commun; 2020 Dec; 533(4):867-871. PubMed ID: 33008593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways.
    Rothan HA; Kumari P; Stone S; Natekar JP; Arora K; Auroni TT; Kumar M
    Pathogens; 2022 Feb; 11(2):. PubMed ID: 35215199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation and Characterization of a SARS-CoV-2-Susceptible Mouse Model Using Adeno-Associated Virus (AAV6.2FF)-Mediated Respiratory Delivery of the Human ACE2 Gene.
    Tailor N; Warner BM; Griffin BD; Tierney K; Moffat E; Frost K; Vendramelli R; Leung A; Willman M; Thomas SP; Pei Y; Booth SA; Embury-Hyatt C; Wootton SK; Kobasa D
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19.
    Oliveira EH; Monteleone-Cassiano AC; Tavares L; Santos JC; Lima TM; Gomes GF; Tanaka PP; Monteiro CJ; Munuera M; Batah SS; Fabro AT; Faça VM; Masson AP; Donadi EA; Dametto M; Bonacin R; Martins RB; Neto EA; daSilva LLP; Cunha TM; Passos GA
    Antiviral Res; 2024 Sep; 229():105968. PubMed ID: 39004311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.